Search
for
Sort by
Research 61–90 of 89
- Phospholipase A2 Is Required for PIN-FORMED Protein Trafficking to the Plasma Membrane in the<i>Arabidopsis</i>Root
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- Cutaneous Reactions to Drugs
- FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation
- (7E)-7,8-Dehydroheliobuphthalmin from Platycladus orientalis L.: Isolation, Characterization, and Hair Growth Promotion
- Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Hair and Scalp Disorders
- SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder
- Dermatology Calendar
- The Fate of Trichohyalin
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Dermatologic manifestations of thyroid disease: a literature review
- Multivariate Profiles of Female Sexual Function: A Cluster Analysis of FSFI Domains in Women with and Without PCOS
- Non-Invasive Methods of Evaluation in Female Pattern Hair Loss : Common Problems in Clinical Practice
- 6581 Case of Conversion from Hashimoto’s Thyroiditis to Graves’ Disease: An Unusual Sequence
- Dermatological drugs and topical agents